World journal of critical care medicine · 2026
Brain-kidney cross-talk: A call for action!
Редакционная статьяКомментарийНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Paulin Susan, Palaniappan Ratthinam
Аннотация
The cascade of events initiated by traumatic brain injury (TBI) has been a major focus of research. Despite significant advances, a deeper understanding of both favorable and unfavorable factors is still needed in this special cohort, especially concerning non-neurological complications - such as respiratory dysfunction, cardiovascular issues, sepsis, and acute kidney injury (AKI). This underscores the need to look beyond the immediate "what kills first" approach and address other critical problems that are essential for both patient management and resource utilization. The brain-kidney cross-talk goes both ways. In this context, Wankhade et al recently published a study in World Journal of Critical Care Medicine, investigating the risk factors that predict the development of AKI following TBI, and the most frequently recognized contributors. TBI can lead to AKI through several pathways, while conversely, AKI can worsen brain injury. While the pathophysiology is increasingly understood, there are limited interventions to prevent AKI in TBI patients. So does identification of predictors and risk factors translate to prevention of AKI here? A precise understanding is needed to help develop targeted interventions rather than just reactive treatments. The search for predictive biomarkers is a promising area of research, especially with regard to early identification of non-neurological complications. Future research must shift towards the development of predictive biomarkers and targeted preventive strategies, ensuring extension of clinical focus beyond immediate life threats and addressing the full spectrum of TBI-related pathophysiology.